2024 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2023 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2022 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2020 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2019 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2017 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2016 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners

2015 Massachusetts General Laws ch. 94C sec. 6A – Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners